Regulatory News:
In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 18 November 2025, it has received a transparency notification from UBS Group AG.
1. Summary of the notification
On 12 November 2025, UBS Group AG (taking into account the holding of all its affiliates) owned 993,365 shares with voting rights, representing 0.41% of the total number of shares issued by the company (243,921,719), as well as 10,718,325 equivalent financial instruments, representing 4.39% of the voting rights issued by the company.
2. Content of the notification
Reason for the notification
Acquisition or disposal of voting securities or voting rights
Notification by
A parent undertaking or a controlling person
Persons subject to the notification requirement
Name | Address (for legal entities) |
UBS Group AG | Bahnhofstrasse 45, 8001 Zürich |
Date on which the threshold is crossed
12 November 2025
Threshold that is crossed (in %)
3%
Denominator
243,921,719
Notified Details
A) Voting rights | Previous
| After the transaction | |||
# of voting
| # of voting rights | % of voting rights | |||
Holders of voting rights | Linked to
| Not linked to
| Linked to
| Not linked to
| |
UBS Group AG | 0 | 0 | 0.00% | 0.00% | |
UBS AG | 59,806 | 0 | 0.02% | 0.00% | |
UBS Europe SE | 18,286 | 0 | 0.01% | 0.00% | |
UBS Switzerland AG | 655,289 | 0 | 0.27% | 0.00% | |
UBS Asset Management (Europe) S.A. | 80,518 | 0 | 0.03% | 0.00% | |
UBS Asset Management Life Limited | 8,128 | 0 | 0.00% | 0.00% | |
UBS Fund Management (Ireland) Ltd. | 72 | 0 | 0.00% | 0.00% | |
UBS Fund Management (Switzerland) AG | 171,266 | 0 | 0.07% | 0.00% | |
Subtotal | 993,365 | 0.41% | |||
TOTAL | 993,365 | 0 | 0.41% | 0.00% | |
B) Equivalent financial instruments | After the transaction | |||||
Holders of equivalent
| Type of financial
| Expiration
| Exercise
| # of voting
| % of voting
| Settlement |
UBS AG | Long Call Option | 17/12/2027 | 177,000 | 0.07% | physical | |
UBS AG | Short Put Option | 19/12/2025 | 500,000 | 0.20% | physical | |
UBS AG | Equity Swaps | 28/03/2028 | 1,938 | 0.00% | cash | |
UBS AG | Right to Recall of Lent shares | At any time | 257,118 | 0.11% | physical | |
UBS AG | Right to Substitute shares delivered as collaterals | At any time | 154,759 | 0.06% | physical | |
UBS Switzerland AG | Right to Recall of Lent shares | At any time | 64,793 | 0.03% | physical | |
UBS Switzerland AG | Right to Substitute shares delivered as collaterals | At any time | 155,218 | 0.06% | physical | |
UBS Switzerland AG | Right of use over shares | At any time | 7,446,832 | 3.05% | physical | |
UBS AG | Right of use over shares | At any time | 1,224,167 | 0.50% | physical | |
UBS Securities LLC | Right of use over shares | At any time | 675,000 | 0.28% | physical | |
UBS AG | Long Call Option | 17/03/2028 | 61,500 | 0.03% | physical | |
TOTAL | 10,718,325 | 4.39% | ||||
TOTAL (A B) | # of voting
| % of voting
| ||
CALCULATE | 11,711,690 | 4.80% |
Chain of controlled undertakings through which the holding is effectively held, if applicable
Please see full chain of control attached.
Additional information
The disclosure obligation arose due to the total indirect holdings of UBS Group AG in voting rights of Azelis Group NV, held directly by controlled undertakings, going above 3% on 12th November 2025.
3. Further information
The full transparency notification as well as this press release can be consulted on the Azelis Group NV's website.
About Azelis
Azelis is the reference global innovation service provider in the speciality chemical and food ingredients industry present in 65 countries across the globe with over 4,300 employees. Our knowledgeable teams of industry, market and technical experts are each dedicated to a specific market within Life Sciences and Industrial Chemicals. We offer a lateral value chain of complementary products to more than 62,000 customers, supported by +2,800 principal relationships, creating a turnover of €4.2 billion (2024). Azelis Group NV is listed on Euronext Brussels under ticker AZE and is included in the BEL20 and BELESG indices.
Across our extensive network of more than 70 application laboratories, our award-winning teams help develop formulations and provide technical guidance throughout the customers' product development process. We combine a global market reach with a local footprint to offer a reliable, integrated, and unique digital service to local customers and attractive business opportunities to principals. Top industry-rated by Sustainalytics, Azelis is a leader in sustainability. We believe in building and nurturing solid, honest, and transparent relationships with our people and partners.
Impact through ideas. Innovation through formulation.
www.azelis.com
Attachment Chain of control
11. Information in relation to the person subject to the notification obligation organizational chart |
UBS Group AG |
UBS AG |
UBS Switzerland AG |
UBS Group AG |
UBS AG |
UBS Europe SE |
UBS Group AG |
UBS AG |
UBS Asset Management AG |
UBS Asset Management (Europe) S.A. |
UBS Group AG |
UBS AG |
UBS Asset Management AG |
UBS Asset Management Holding (No. 2) Ltd |
UBS Asset Management Holding Ltd |
UBS Asset Management Life Ltd |
UBS Group AG |
UBS AG |
UBS Fund Management (Ireland) Ltd. |
UBS Group AG |
UBS AG |
UBS Asset Management AG |
UBS Asset Management Switzerland AG |
UBS Fund Management (Switzerland) AG |
UBS Group AG |
UBS AG |
UBS Americas Holding LLC |
UBS Americas Inc. |
UBS Securities LLC |
View source version on businesswire.com: https://www.businesswire.com/news/home/20251119539599/en/
Contacts:
Azelis
investor-relations@azelis.com
